FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23449 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Triamcinolone acetonide 40mg injection suspension ampule Triamcinolone only product in parenteral dose form
Triamcinolone acetonide 40mg/mL suspension Product containing only triamcinolone (medicinal product)
Triamcinolone diacetate 25mg/mL injection suspension ampule Triamcinolone diacetate 25 mg/mL suspension for injection
Triamcinolone diacetate 40mg/mL injection suspension ampule Product containing precisely triamcinolone diacetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug)
Triazole derivative Substance with triazole structure (substance)
Tribavirin 6g inhalation (pdr for recon) Product containing precisely ribavirin 20 milligram/1 milliliter conventional release solution for inhalation (clinical drug)
Tricho-thiodystrophy A rare, genetic, syndromic hair shaft abnormality disorder characterised by short, dry, sulphur-deficient, brittle hair usually associated with highly variable neuroectodermal manifestations, such as ichthyosis, photosensitivity, and intellectual disability.
Trichoglossus haematodos forsteni Trichoglossus forsteni (organism)
Trichomoniasis of other sites Infection by Trichomonas
Trichosporon capitatum Magnusiomyces capitatus
Triclofos sodium allergy Allergy to triclofos
Triclosan 2% bath additive Triclosan 20 mg/mL cutaneous solution
Tricuspid valve regurgitation due to carcinoid tumor Tricuspid valve regurgitation due to neuroendocrine tumor (disorder)
Tricuspid valve stenosis due to carcinoid tumor Tricuspid valve stenosis due to neuroendocrine tumour
Tricuspid valve stenosis with regurgitation due to carcinoid tumor Tricuspid valve stenosis with regurgitation due to neuroendocrine tumor (disorder)
Triethanolamine polypeptide oleate condensate 10% solution Product containing only triethanolamine in otic dose form (medicinal product form)
Trifluoperazine hydrochlorid 1mg tablet Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)
Trifluoperazine hydrochlorid 5mg tablet Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug)
Trifluoperazine hydrochloride 10mg/mL solution Trifluoperazine 10 mg/mL oral solution
Trigeminal nerve disorder NOS Trigeminal nerve disorder
Trigeminal nerve disorder NOS Trigeminal nerve disorder
Trigemino-sympathetic syndrome Paratrigeminal syndrome
Trihexyphenidyl hydrochloride 5mg m/r capsule Product containing only trihexyphenidyl in oral dose form (medicinal product form)
Trihexyphenidyl hydrochloride 5mg prolonged-release oral capsule Product containing only trihexyphenidyl in oral dose form (medicinal product form)
Trimellitic anhydride specific extract Trimellitic acid
Trimesters Temporal period relating to mother from conception until the onset of labour.
Trimethobenzamide 100mg/mL Trimethobenzamide hydrochloride 100 mg/mL solution for injection
Trimethobenzamide hydrochlor 100mg/mL solution Trimethobenzamide hydrochloride 100 mg/mL solution for injection
Trimethobenzamide hydrochloride 100 mg/mL intramuscular solution Trimethobenzamide hydrochloride 100 mg/mL solution for injection
Trimethobenzamide hydrochloride 100mg suppositories Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 100 milligram/1 each conventional release rectal suppository (clinical drug)
Trimethobenzamide hydrochloride 100mg/mL bar Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 100 milligram/1 each conventional release rectal suppository (clinical drug)
Trimethobenzamide hydrochloride 100mg/mL injection solution ampule Trimethobenzamide hydrochloride 100 mg/mL solution for injection
Trimethobenzamide hydrochloride 200mg suppository Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 200 milligram/1 each conventional release rectal suppository (clinical drug)
Trinitrotoluene, device Trinitrotoluene (substance)
Triphalangeal thumbs with onychodystrophy A rare multiple congenital anomalies-intellectual disability syndrome characterized by sensorineural hearing loss (deafness), onychodystrophy, osteodystrophy, mild to profound intellectual disability, and seizures.
Triphosphoric monoester hydrolase Triphosphoric monoester hydrolase
Triprolidine hydrochloride 100% Product containing triprolidine (medicinal product)
Triptorelin pamoate 11.25mg/vial lyophilized powder for conventional release suspension for injection Triptorelin only product in parenteral dose form
Triptorelin pamoate 11.25mg/vial powder Triptorelin only product in parenteral dose form
Triptorelin pamoate 3.75mg/vial lyophilized powder for conventional release suspension for injection Triptorelin only product in parenteral dose form
Triptorelin pamoate 3.75mg/vial powder Triptorelin only product in parenteral dose form
Trisodium edetate allergy Allergy to edetate (finding)
Tritiarchium Tritirachium
Tritiarchium oryzae Tritirachium oryzae
Trochanteric transplant Osteotomy and transfer of greater trochanter
Trophic ulcer Neurogenic ulcer
Tropicamide 0.5% conventional release eye drops Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Tropicamide 0.5% single-use eye drops Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Tropicamide 1% conventional release eye drops Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug)
Tropicamide 1% single-use eye drops Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug)
Trout - dietary Trout (substance)
True bug Order Hemiptera (organism)
True histiocytic lymphoma Histiocytic sarcoma
True yeast Order Saccharomycetales (organism)
Trunk angiography NOS Angiography of blood vessel of trunk
Trunk angiography NOS Angiography of blood vessel of trunk
Trunk flap Flap (substance)
Trunk soft tissue X-ray Plain X-ray of soft tissue of trunk (procedure)
Trypan blue 0.06% ophthalmic solution Trypan blue stain only product
Trypan blue 1.5mg/mL ophthalmic solution Trypan blue stain only product
Trypanocides[no drugs here] Antiprotozoal
Tryptase Tryptase
Tsukamurella wratislaviensis Rhodococcus wratislaviensis (organism)
Tubal abortion Miscarriage of tubal ectopic pregnancy
Tubal-cornual placenta Cornual placenta accreta
Tube feeding by Barron pump Enteral feeding
Tuberculin PPD 100,000units/mL injection solution 1mL ampule Product containing precisely tuberculin purified protein derivative 100000 unit/1 milliliter conventional release solution for injection (clinical drug)
Tuberculin PPD 1:10,000(10units/mL) injection solution 1mL ampule Product containing precisely tuberculin purified protein derivative 10 unit/1 milliliter conventional release solution for injection (clinical drug)
Tuberculin PPD 1:100(1000units/mL) injection solution 1mL ampule Tuberculin purified protein derivative 1000 unit/mL solution for injection
Tuberculin PPD 1:1000(100units/mL) injection solution 1mL ampule Product containing precisely tuberculin purified protein derivative 100 unit/1 milliliter conventional release solution for injection (clinical drug)
Tuberculin, purified protein 1u/mL injection solution vial Tuberculin purified protein derivative 50 unit/mL solution for injection
Tuberculosis NOS Tuberculosis
Tuberculosis NOS Tuberculosis
Tuberculosis of cervical lymph nodes Cervical tuberculous lymphadenitis
Tuberculosis of other female genital organs Tuberculosis of female genital organs
Tuberculosis of other organs Tuberculosis
Tuberculosis of other organs Tuberculosis
Tuberculosis of other organs NOS Tuberculosis
Tuberculosis of other specified bone Tuberculosis of bone
Tuberculosis of other specified joint Tuberculous arthritis
Tuberculosis of other specified joint Tuberculous arthritis
Tuberculosis of other urinary organs Tuberculosis of urinary organs
Tuberculosis of other urinary organs (disorder) Primary progressive tuberculosis
Tuberculosis of peritoneum Tuberculous peritonitis
Tuberculous Tuberculous (qualifier value)
Tuberculous spondylitis Tuberculosis of vertebral column
Tubular adenoma - category Benign tubular adenoma (morphologic abnormality)
Tubular adenoma, no International Classification of Diseases for Oncology subtype Benign tubular adenoma (morphologic abnormality)
Tumor grade GB American Joint Committee on Cancer grade GB (qualifier value)
Tumor of uterine body affecting obstetric care Neoplasm of body of uterus in pregnancy, childbirth and puerperium
Tumor stage T1a American Joint Committee on Cancer cT1a (qualifier value)
Tumor stage T1a1 American Joint Committee on Cancer cT1a1 (qualifier value)
Tumor stage T1a2 American Joint Committee on Cancer cT1a2 (qualifier value)
Tumor stage T1b American Joint Committee on Cancer cT1b (qualifier value)
Tumor stage T1b1 American Joint Committee on Cancer cT1b1 (qualifier value)
Tumor stage T1b2 American Joint Committee on Cancer cT1b2 (qualifier value)
Tumor stage T1c American Joint Committee on Cancer cT1c (qualifier value)
Tumor stage T1mic American Joint Committee on Cancer cT1mi (qualifier value)
Tumor stage T2a American Joint Committee on Cancer cT2a (qualifier value)
Tumor stage T2b American Joint Committee on Cancer cT2b (qualifier value)
Tumor stage T2c American Joint Committee on Cancer cT2c (qualifier value)

Start Previous Page 214 of 235 Next End


Reference Sets

Reference set descriptor

Back to Start